Information for "Improvement inside immune disorder soon after FOLFOX chemo for Phase Three colon cancer is associated with improved upon minimal continuing condition prognostic subtype along with result"
From EECH Central
Basic information
| Display title | Improvement inside immune disorder soon after FOLFOX chemo for Phase Three colon cancer is associated with improved upon minimal continuing condition prognostic subtype along with result |
| Default sort key | Improvement inside immune disorder soon after FOLFOX chemo for Phase Three colon cancer is associated with improved upon minimal continuing condition prognostic subtype along with result |
| Page length (in bytes) | 3,311 |
| Page ID | 1416160 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Officeowl96 (Talk | contribs) |
| Date of page creation | 11:34, 28 April 2024 |
| Latest editor | Officeowl96 (Talk | contribs) |
| Date of latest edit | 11:34, 28 April 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
